| Literature DB >> 35627941 |
Robert M Avina1, Jim E Banta1, Ronald Mataya1, Benjamin J Becerra2, Monideepa B Becerra3.
Abstract
BACKGROUND: Empirical evidence demonstrates the substantial burden of mental illness among people living with HIV and AIDS (PLWHA). Current literature also notes the co-morbidity of these two illnesses and its impact on quality of life and mortality. However, little evidence exists on patient outcomes, such as hospital length of stay or post-discharge status.Entities:
Keywords: HIV; length of stay; mental health; mental illness; post-discharge; routine disposition
Year: 2022 PMID: 35627941 PMCID: PMC9140380 DOI: 10.3390/healthcare10050804
Source DB: PubMed Journal: Healthcare (Basel) ISSN: 2227-9032
Characteristics of primary HIV discharges in the United States.
| Variables | Population Estimate (N) | Survey-Weighted Percent |
|---|---|---|
|
| 7595 | 29.15 |
|
| 11,400 | 43.75 |
|
| ||
| Congestive Heart Failure | 2265 | 7.42 |
| Valvular Disease | 580 | 1.90 |
| Pulmonary Circulation Disease | 355 | 1.16 |
| Peripheral Vascular Disease | 325 | 1.06 |
| Paralysis | 940 | 3.08 |
| Other Neurological Disorders | 3155 | 10.33 |
| Chronic Pulmonary Disease | 5960 | 19.52 |
| Diabetes w/o Chronic Complications | 1240 | 4.06 |
| Diabetes with Chronic Complications | 1720 | 5.63 |
| Hypothyroidism | 830 | 2.72 |
| Renal Failure | 3825 | 12.53 |
| Liver Disease | 3170 | 10.40 |
| Peptic Ulcer Disease Bleeding | 215 | 0.70 |
| Lymphoma | 1500 | 4.91 |
| Metastatic cancer | 435 | 1.42 |
| Solid Tumor without Metastasis | 475 | 1.60 |
| Rheumatoid Arthritis/Collagen Vascular Disease | 265 | 0.87 |
| Coagulopathy | 3745 | 12.27 |
| Obesity | 1385 | 4.54 |
| Weight Loss | 7630 | 25.00 |
| Fluid and Electrolyte Disorders | 13,405 | 43.91 |
| Chronic Blood Loss Anemia | 200 | 0.66 |
| Deficiency Anemias | 9850 | 32.30 |
| Hypertension | 8430 | 27.61 |
|
| ||
|
| ||
| 18–34 years | 6215 | 23.90 |
| 35–49 years | 9535 | 36.68 |
| 50–64 years | 8720 | 33.54 |
| 65 years + | 1525 | 5.86 |
|
| ||
| Male | 18,290 | 70.22 |
| Female | 7755 | 29.77 |
|
| ||
| White | 6320 | 24.79 |
| Black | 13,880 | 54.46 |
| Hispanic | 3860 | 15.14 |
| Other | 1425 | 5.59 |
|
| ||
| USD 1–43,999 | 13,155 | 52.03 |
| USD 44,000–55,999 | 5335 | 21.10 |
| USD 56,000–73,999 | 4165 | 16.47 |
| USD 74,000 or more | 2625 | 10.38 |
|
| ||
| Medicare | 6565 | 25.25 |
| Medicaid | 11,350 | 43.65 |
| Private including HMO | 4585 | 17.63 |
| Other | 3500 | 13.46 |
|
| ||
|
| ||
| Small | 3975 | 15.25 |
| Medium | 6925 | 26.57 |
| Large | 15,155 | 58.16 |
|
| ||
| Government, Nonfederal | 5120 | 19.65 |
| Private, Non-profit | 17,700 | 67.93 |
| Private, Investor-owned | 3235 | 12.41 |
|
| ||
| Rural | 740 | 2.84 |
| Urban Non-teaching | 4170 | 16.00 |
| Urban Teaching | 21,145 | 81.15 |
|
| ||
| Northeast | 5020 | 19.26 |
| Midwest | 3175 | 12.18 |
| South | 13,690 | 52.54 |
| West | 4170 | 16.00 |
Prevalence of any mental illness by patient and hospital characteristics of primary HIV discharges in the United States.
| Variables | Survey-Weighted Prevalence (%) |
|---|---|
|
| |
| Congestive Heart Failure | 29.58 |
| Valvular Disease | 67.24 |
| Pulmonary Circulation Disease * | 40.85 |
| Peripheral Vascular Disease | 23.08 |
| Paralysis | 32.45 |
| Other Neurological Disorders *** | 35.66 |
| Chronic Pulmonary Disease *** | 37.58 |
| Diabetes without Chronic Complications | 28.63 |
| Diabetes with Chronic Complications | 28.49 |
| Hypothyroidism *** | 44.58 |
| Renal Failure ** | 25.10 |
| Liver Disease *** | 34.86 |
| Peptic Ulcer Disease Bleeding * | 16.28 |
| Lymphoma | 25.00 |
| Metastatic cancer | 25.29 |
| Solid Tumor without Metastasis | 33.68 |
| Rheumatoid Arthritis/Collagen Vascular Disease | 35.85 |
| Coagulopathy | 27.10 |
| Obesity | 33.57 |
| Weight Loss | 28.83 |
| Fluid and Electrolyte Disorders ** | 27.45 |
| Chronic Blood Loss Anemia ** | 10.00 |
| Deficiency Anemias * | 29.34 |
| Hypertension * | 31.26 |
|
| 37.32 |
|
| |
|
| |
| 18–34 years | 27.92 |
| 35–49 years | 30.05 |
| 50–64 years | 30.28 |
| 65 years or more | 22.30 |
|
| |
| Male | 26.68 |
| Female | 34.95 |
|
| |
| White | 38.29 |
| Black | 26.51 |
| Hispanic | 25.26 |
| Other | 24.91 |
|
| |
| USD 1–43,999 | 29.34 |
| USD 44,000–55,999 | 30.55 |
| USD 56,000–73,999 | 29.17 |
| USD 74,000 or more | 24.76 |
|
| |
| Medicare | 35.80 |
| Medicaid | 29.78 |
| Private including HMO | 21.81 |
| Other | 24.57 |
|
| |
|
| |
| Small | 30.31 |
| Medium | 27.29 |
| Large | 29.69 |
|
| |
| Governmental, Nonfederal | 28.13 |
| Private, Non-profit | 29.55 |
| Private, Investor-own | 28.59 |
|
| |
| Rural | 26.35 |
| Urban Non-teaching | 23.14 |
| Urban Teaching | 30.43 |
|
| |
| Northeast | 32.37 |
| Midwest | 34.02 |
| South | 27.25 |
| West | 27.82 |
* p < 0.05, ** p < 0.01, *** p < 0.001.
Impact of secondary mental illness on hospital length of stay (LOS) among primary HIV discharges in the United States.
| Variables | IRR (95% CI) |
|---|---|
|
| 1.12 (1.05, 1.21) |
|
| |
| Absence | Reference |
| Presence | 0.80 (0.75, 0.86) |
|
| |
| No Co-morbidity | Reference |
| Congestive Heart Failure | 1.14 (1.00, 1.30) |
| Valvular Disease | 0.91 (0.75, 1.11) |
| Pulmonary Circulation Disease ** | 1.52 (1.17, 1.99) |
| Peripheral Vascular Disease * | 1.37 (1.06, 1.76) |
| Paralysis *** | 1.78 (1.45, 2.19) |
| Other Neurological Disorders *** | 1.50 (1.33, 1.69) |
| Chronic Pulmonary Disease | 0.98 (0.91, 1.06) |
| Diabetes without Chronic Complications | 1.16 (0.88, 1.54) |
| Diabetes with Chronic Complications | 1.07 (0.93, 1.23) |
| Hypothyroidism | 1.07 (0.86, 1.32) |
| Renal Failure | 1.08 (0.98, 1.20) |
| Liver Disease | 1.07 (0.94, 1.22) |
| Peptic Ulcer Disease Bleeding * | 1.35 (1.04, 1.77) |
| Lymphoma *** | 1.25 (1.12, 1.39) |
| Metastatic cancer | 1.04 (0.85, 1.29) |
| Solid Tumor without Metastasis | 0.99 (0.84, 1.17) |
| Rheumatoid Arthritis/Collagen Vascular Disease | 1.21 (0.92, 1.60) |
| Coagulopathy *** | 1.24 (1.15, 1.34) |
| Obesity | 1.10 (0.93, 1.30) |
| Weight Loss *** | 1.40 (1.31, 1.50) |
| Fluid and Electrolyte Disorders *** | 1.41 (1.31, 1.51) |
| Chronic Blood Loss Anemia | 1.09 (0.82, 1.45) |
| Deficiency Anemias * | 1.07 (1.00, 1.14) |
| Hypertension | 1.01 (0.93, 1.10) |
|
| |
|
| |
| 18–34 years | Reference |
| 35–49 years | 1.01 (0.92, 1.10) |
| 50–64 years | 1.03 (0.95, 1.12) |
| 65 years or more | 1.09 (0.94, 1.26) |
|
| |
| Male | Reference |
| Female | 0.95 (0.88, 1.03) |
|
| |
| White | Reference |
| Black * | 1.10 (1.01, 1.20) |
| Hispanic | 1.07 (0.96, 1.20) |
| Other | 1.00 (0.87, 1.14) |
|
| |
| USD 74,000 or more | Reference |
| USD 1–43,999 | 1.00 (0.89, 1.12) |
| USD 44,000–55,999 | 1.05 (0.93, 1.19) |
| USD 56,000–73,999 | 1.06 (0.94, 1.20) |
|
| |
| Medicare | Reference |
| Medicaid *** | 1.28 (1.17, 1.39) |
| Private including HMO ** | 1.16 (1.05, 1.28) |
| Other ** | 1.27 (1.12, 1.44) |
|
| |
|
| |
| Small | Reference |
| Medium *** | 1.21 (1.09, 1.33) |
| Large *** | 1.29 (1.18, 1.41) |
|
| |
| Governmental, Nonfederal | Reference |
| Private, Non-profit * | 0.88 (0.80, 0.98) |
| Private, Investor-own | 0.92 (0.80, 1.05) |
|
| |
| Rural | Reference |
| Urban Non-teaching | 1.09 (0.91, 1.32) |
| Urban Teaching ** | 1.30 (1.08, 1.56) |
|
| |
| Northeast | Reference |
| Midwest *** | 0.76 (0.67, 0.86) |
| South | 0.90 (0.80, 1.02) |
| West | 0.89 (0.79, 1.02) |
* p < 0.05, ** p < 0.01, *** p < 0.001.